Intellego Technologies

Background
At the Extraordinary General Meeting in Intellego held on 5 May 2021 it was resolved on a directed issue of 700,000 warrants of series TO 2021/2024B to the Company’s former Board members Per-Ola Rosenqvist, Björn Wetterling, Henrik Börjesson and Anders Ardstål. Each Warrant gave the holder right to subscribe for one share in the Company during the period from and including 29 April 2024 up to and including 29 October 2024. The subscription price for the Warrants amounted to SEK 14.40 per exercised Warrant.

The former Board members Per-Ola Rosenqvist and Björn Wetterling have exercised in total 350,000 Warrants, corresponding to 50 percent of the issued Warrants, for the subscription of 350,000 shares at a subscription price amounting to SEK 14.40 per exercised Warrant. Through the exercise of the Warrants Intellego receives approximately SEK 5.0 million before issuing costs.

Earlier, the former Board members Henrik Börjesson and Anders Ardstål exercised, in total, 350,000 Warrants, as announced by the Company via a press release on 15 May 2024. In total, 700,000 Warrants, corresponding to 100 percent of the issued Warrants, have been exercised for the subscription of shares.

Number of shares, share capital and dilution
Through the exercise of the Warrants the number of shares in Intellego increases by a total of 350,000 shares, from 28,439,186 shares to 28,789,186 shares and the share capital increases by approximately SEK 12,500.00, from approximately SEK 1,015,685.23 to approximately SEK 1,028,185.23, taking into account the directed issue of units communicated by the Company on 19 September 2024. The exercise of the Warrants entails a dilution of approximately 1.22 percent of the total number of shares and votes based on the number of shares and votes after the directed issue of units, communicated on 19 September 2024, and after the exercise of the Warrants.

Advisers
Fredersen Advokatbyrå acts as legal advisor to Intellego and Mangold Fondkommission AB acts as issuing agent in connection with the exercise of the Warrants.